英国生物银行与SAIL数据库中的多病共存与不良健康结局关联:纵向队列研究的比较
该研究比较了英国生物银行(n=211,597)与SAIL数据库(n=852,055)中40至70岁人群多病共存与全因死亡、非计划住院及主要不良心血管事件的关联。UK Biobank中≥2种长期病症者占26.9%,低于SAIL的33.0%。长期病症数≤3时两队列风险估计相似,≥4时UK Biobank低估了关联强度;UK Biobank中各多病共存水平的绝对风险均低于SAIL。
要点
- UK Biobank中≥2种长期病症者占26.9%,SAIL中占33.0%,UK Biobank多病共存较少见。
- 长期病症数≤3时两队列死亡、住院和MACE的风险估计相似。
- 长期病症数≥4时UK Biobank低估了多病共存相关风险,如5种病症死亡HR在SAIL为3.46、UK Biobank为2.88。
核心结论
- UK Biobank可准确估计长期病症数≤3时与死亡、非计划住院和MACE相关的相对风险。
- 对于长期病症数≥4及某些病症组合,UK Biobank的关联强度估计可能偏保守。
- 研究者在使用UK Biobank进行多病共存分析时应留意这些局限。
研究设计与样本
- 研究为观察性队列分析,数据来自UK Biobank参与者(n=211,597,来自英格兰、苏格兰和威尔士,年龄40至70岁,平均年龄56.5岁,54.6%为女性,基线评估2006至2010年)和SAIL数据库(n=852,055,来自威尔士,年龄40至70岁,平均年龄54.2岁,50.0%为女性,基线2011年1月)的关联常规医疗数据。
- 多病共存通过初级保健Read码识别40种长期病症,并用简单计数和加权评分量化,同时评估单个长期病症及病症组合。
- 使用Weibull或负二项模型评估与全因死亡、非计划住院和MACE的关联,调整年龄、性别和社会经济地位,两数据集随访均为7.5年。
主要发现
- UK Biobank中≥2种长期病症者占26.9%,SAIL中占33.0%,按年龄、性别和社会经济地位标准化后差异减弱但仍存在。
- 长期病症数为2时死亡HR在SAIL为1.62(95%CI 1.57至1.68),在UK Biobank为1.51(95%CI 1.43至1.59);长期病症数为5时死亡HR在SAIL为3.46(95%CI 3.31至3.61),在UK Biobank为2.88(95%CI 2.63至3.15)。
- 在所有多病共存水平,调整年龄、性别和社会经济地位后,UK Biobank中死亡、住院和MACE的绝对风险均低于SAIL。
- 两队列对某些长期病症(如高血压和冠心病)产生相似的HR,但UK Biobank低估了其他病症(如酒精相关障碍或精神健康状况)的风险。
- 某些病症组合(如心血管疾病)的HR在两队列间相似,但UK Biobank低估了包含其他病症(如精神健康状况)的组合风险。
关键数值与推荐
- 多病共存定义为40种长期病症,用简单计数和加权评分量化。
- 主要结局为全因死亡、非计划住院和MACE,随访7.5年。
临床怎么用
- 原文未据此给出推荐。
局限性
- SAIL数据库仅代表英国的一部分(仅威尔士)。
- 两个队列均缺乏所纳入长期病症严重程度的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cohorts such as UK Biobank are increasingly used to study multimorbidity; however, there are concerns that lack of representativeness may lead to biased results. This study aims to compare associations between multimorbidity and adverse health outcomes in UK Biobank and a nationally representative sample. METHODS AND FINDINGS: These are observational analyses of cohorts identified from linked routine healthcare data from UK Biobank participants (n = 211,597 from England, Scotland, and Wales with linked primary care data, age 40 to 70, mean age 56.5 years, 54.6% women, baseline assessment 2006 to 2010) and from the Secure Anonymised Information Linkage (SAIL) databank (n = 852,055 from Wales, age 40 to 70, mean age 54.2, 50.0% women, baseline January 2011). Multimorbidity (n = 40 long-term conditions [LTCs]) was identified from primary care Read codes and quantified using a simple count and a weighted score. Individual LTCs and LTC combinations were also assessed. Associations with all-cause mortality, unscheduled hospitalisation, and major adverse cardiovascular events (MACEs) were assessed using Weibull or negative binomial models adjusted for age, sex, and socioeconomic status, over 7.5 years follow-up for both datasets. Multimorbidity was less common in UK Biobank than SAIL (26.9% and 33.0% with ≥2 LTCs in UK Biobank and SAIL, respectively). This difference was attenuated, but persisted, after standardising by age, sex, and socioeconomic status. The association between increasing multimorbidity count and mortality, hospitalisation, and MACE was similar between both datasets at LTC counts of ≤3; however, above this level, UK Biobank underestimated the risk associated with multimorbidity (e.g., mortality hazard ratio for 2 LTCs 1.62 (95% confidence interval 1.57 to 1.68) in SAIL and 1.51 (1.43 to 1.59) in UK Biobank, hazard ratio for 5 LTCs was 3.46 (3.31 to 3.61) in SAIL and 2.88 (2.63 to 3.15) in UK Biobank). Absolute risk of mortality, hospitalisation, and MACE, at all levels of multimorbidity, was lower in UK Biobank than SAIL (adjusting for age, sex, and socioeconomic status). Both cohorts produced similar hazard ratios for some LTCs (e.g., hypertension and coronary heart disease), but UK Biobank underestimated the risk for others (e.g., alcohol-related disorders or mental health conditions). Hazard ratios for some LTC combinations were similar between the cohorts (e.g., cardiovascular conditions); however, UK Biobank underestimated the risk for combinations including other conditions (e.g., mental health conditions). The main limitations are that SAIL databank represents only part of the UK (Wales only) and that in both cohorts we lacked data on severity of the LTCs included. CONCLUSIONS: In this study, we observed that UK Biobank accurately estimates relative risk of mortality, unscheduled hospitalisation, and MACE associated with LTC counts ≤3. However, for counts ≥4, and for some LTC combinations, estimates of magnitude of association from UK Biobank are likely to be conservative. Researchers should be mindful of these limitations of UK Biobank when conducting and interpreting analyses of multimorbidity. Nonetheless, the richness of data available in UK Biobank does offers opportunities to better understand multimorbidity, particularly where complementary data sources less susceptible to selection bias can be used to inform and qualify analyses of UK Biobank.
引用
- Hanlon P, Jani BD, Nicholl B, et al. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies. PLoS Med. 2022. PMID: 35255092. doi:10.1371/journal.pmed.1003931
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。